ArticleFrontiers in pharmacology2012

Cardiac Safety Implications of hNav1.5 Blockade and a Framework for Pre-Clinical Evaluation.

Gül Erdemli et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.